SIGFOX
19.5.2021 09:37:05 CEST | Business Wire | Press release
Sabesp, one of the largest water and sewage service providers in the world, today announces that it has successfully completed the implementation of 100,000 smart water meters with Internet of Things (IoT) technology. The project, which is one of the largest in Latin America, introduces water consumption telemeasurement in Sabesp's 100,000 largest consumers in the Metropolitan Region of São Paulo.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210519005356/en/
The Metrolink consortium is delivering the project and comprises of companies Laager and Vita Ambiental, which won the contract after a competitive bidding process Sabesp started at the end of 2018.
WND's Sigfox 0G network was the communication technology selected by Sabesp for more than 92,000 of the total connected water meters. WND is the exclusive operator of Sigfox technology in Brazil. Sigfox technology enables the transport of data wirelessly, at low cost, over long distances, with minimum energy consumption. The devices will be in operation for at least five years without changing or recharging the battery.
Telemetering – the remote reading of meters – automates the process of measuring water consumption. The task was performed manually once a month and can now be performed multiple times a day. In addition to measurement, the system also generates alarms and important statistics about the operation of the entire water network. All of these new features bring reliability, transparency and savings to consumers and unprecedented operational efficiency for Sabesp.
Ricardo Batista, Sabesp's Division Manager and responsible for the project, comments: "The project marked the large-scale adoption of the IoT concept by Sabesp. The new technology enables our customers to monitor water consumption daily, as well as leak detection, saving money and preserving the environment, in addition to better management of resources by our company. We hope to be able to expand the project in the coming years ."
According to Felipe Duque Estrada, CEO of Laager , the success of the project is largely due to the partnership with Sigfox and WND Brazil: "The adoption of 0G network technologies from Sigfox ensured the economic and technological viability of the project. "
José Almeida, Deputy CEO of WND Brazil , adds: "Thanks to Sabesp's pioneering approach, Laager's expertise and our work together, we have delivered one of the largest IoT projects in the Americas. The results achieved demonstrate, without any doubt, that our technology and business model are the best choices for IoT projects today. "
Carlos Beato, VP Americas at Sigfox concludes: “We are incredibly proud of SABESP’s achievement and visionary take on smart water metering. The benefits of such a solution go far beyond remote reading. It truly transforms the customer experience and Quality of Service. ”
*****
Sabesp – Companhia de Saneamento Básico do Estado de São Paulo (http://www.sabesp.com.br/ ) is the largest sanitation company in the Americas and the fourth largest in the world in the population served. It is responsible for the supply of water, sewage collection and treatment in 375 municipalities in the State of São Paulo, besides representing 30% of the investment in basic sanitation made in Brazil.
Laager Tecnologias Sustentáveis Ltda is a company specialized in technological solutions aimed at sustainability. Its devices make it possible to control the consumption of water, gas and electricity, besides allowing greater efficiency in consumption. The company has an advanced system of individualization of these resources, which can be applied to small, medium and large consumers.
Vita Ambiental is a traditional specialized Engineering Services provider for sanitation companies, focusing on reducing losses and operational optimizations.
WND Brazil , which is part of the WND Group (https://www.wndgroup.io/ ), operates in the IoT (Internet of Things) market through the implementation of a national public network, in a B2B (Business to Business) model that allows the sale of connectivity at low cost. In just three years of operation in Brazilian territory, the company is already present in all capital cities of the country, covering an area with a population of more than 120 million inhabitants and serving more than 360 cities. WND Brazil is a pioneer in a national public network dedicated exclusively to IoT using Sigfox technology.
Sigfox is the 0G network pioneer and the world’s leading IoT (Internet of Things) service provider. Sigfox offers a unique combination of ultra-low cost and ultra-low power technologies supported by a global network, enabling businesses to gain visibility and track their assets worldwide. With more than 17 million connected devices and 70 million messages sent a day, Sigfox helps its customers to extract crucial data at the lowest cost and to accelerate their digital transformation in key areas such as Asset Tracking and Supply Chain.
ISO 9001 certified and surrounded by a large ecosystem of partners and IoT key players, Sigfox was founded in 2010 and is headquartered in Labège, France, with offices in Boston, Dallas, Dubai, Madrid, Paris, Sao Paulo, Singapore and Tokyo.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210519005356/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
